NasdaqGS - Nasdaq Real Time Price
USD
Olema Pharmaceuticals, Inc. (OLMA)
7.00
-0.33
(-4.50%)
At close: October 30 at 4:00:01 PM EDT
7.00
0.00
(0.00%)
After hours: October 30 at 4:00:15 PM EDT
Trade OLMA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
1.54M | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -13,937,148 |
| % Change in Institutional Shares Held | -13.30% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HARMON CYRUS Director |
Sale at price 11.58 - 11.71 per share. | Direct | 291,162 | Jul 24, 2026 |
| MITCHELL SHAWNTE Officer |
Sale at price 23.01 - 24.69 per share. | Direct | 951,503 | Mar 4, 2026 |
| MITCHELL SHAWNTE Officer |
Conversion of Exercise of derivative security at price 4.37 per share. | Direct | 174,800 | Mar 4, 2026 |
| AUSTIN SASHA LU Officer |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2026 |
| HARMON CYRUS Director |
Sale at price 26.88 per share. | Direct | 268,800 | Jan 20, 2026 |
| KOVACS SHANE WILLIAM CHARLES Chief Operating Officer |
Sale at price 28.01 - 28.73 per share. | Direct | 2,980,054 | Jan 15, 2026 |
| HARMON CYRUS Director |
Sale at price 29.12 per share. | Direct | 101,600 | Jan 14, 2026 |
| MYLES DAVID C Officer |
Sale at price 27.60 - 28.99 per share. | Indirect | 3,107,229 | Jan 14, 2026 |
| MYLES DAVID C Officer |
Conversion of Exercise of derivative security at price 4.87 per share. | Direct | 487,000 | Jan 14, 2026 |
| BOHEN SEAN Chief Executive Officer |
Stock Gift at price 0.00 per share. | Direct | 0 | Dec 26, 2025 |
| ZOJWALLA NASEEM M.D. Officer |
Sale at price 27.66 - 28.93 per share. | Direct | 7,530,148 | Dec 23, 2025 |
| ZOJWALLA NASEEM M.D. Officer |
Conversion of Exercise of derivative security at price 7.02 - 15.25 per share. | Direct | 1,664,392 | Dec 23, 2025 |
| HARMON CYRUS Director |
Sale at price 28.53 per share. | Direct | 82,195 | Dec 22, 2025 |
| MYLES DAVID C Officer |
Stock Gift at price 0.00 per share. | Direct | 0 | Dec 19, 2025 |
| CLARK IAN THORNTON Director |
Sale at price 28.83 - 30.48 per share. | Direct | 7,873,109 | Dec 19, 2025 |
| MYLES DAVID C Officer |
Sale at price 28.08 - 31.39 per share. | Direct | 1,553,544 | Dec 19, 2025 |
| CLARK IAN THORNTON Director |
Conversion of Exercise of derivative security at price 3.61 - 7.84 per share. | Direct | 1,219,544 | Dec 19, 2025 |
| KOVACS SHANE WILLIAM CHARLES Officer |
Stock Gift at price 0.00 per share. | Direct | 0 | Dec 8, 2025 |
| KOVACS SHANE WILLIAM CHARLES Chief Operating Officer |
Stock Gift at price 0.00 per share. | Direct | 0 | Nov 26, 2025 |
| RAPPAPORT ANDREW S Director |
Stock Gift at price 0.00 per share. | Direct | 0 | Nov 25, 2025 |
| RAPPAPORT ANDREW S Director |
Conversion of Exercise of derivative security at price 0.39 per share. | Direct | 13,989 | Nov 21, 2025 |
| HARMON CYRUS Director |
Sale at price 8.04 - 8.33 per share. | Indirect | 204,841 | Sep 18, 2025 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 5.76 per share. | Indirect | 1,727,370 | Jan 8, 2025 |
| GRAHAM G. WALMSLEY Director |
Purchase at price 6.75 per share. | Indirect | 4,730,137 | Dec 17, 2024 |
| GRAHAM G. WALMSLEY Director |
Purchase at price 6.75 per share. | Indirect | 4,730,137 | Dec 17, 2024 |
| GRAHAM G. WALMSLEY Director |
Sale at price 6.75 per share. | Indirect | 4,730,137 | Dec 17, 2024 |
| GRAHAM G. WALMSLEY Director |
Sale at price 6.75 per share. | Indirect | 4,730,137 | Dec 17, 2024 |
| ZOJWALLA NASEEM M.D. Officer |
Conversion of Exercise of derivative security at price 4.87 per share. | Direct | 68,180 | Dec 16, 2024 |
| GRAHAM G. WALMSLEY Director |
Purchase at price 6.75 per share. | Indirect | 4,730,137 | Dec 13, 2024 |
| GRAHAM G. WALMSLEY Director |
Sale at price 6.75 per share. | Indirect | 4,730,137 | Dec 13, 2024 |
| KOVACS SHANE WILLIAM CHARLES Officer |
Sale at price 8.66 - 9.39 per share. | Direct | 316,703 | Dec 11, 2024 |
| HARMON CYRUS Director |
Sale at price 8.66 - 9.39 per share. | Direct | 147,956 | Dec 11, 2024 |
| MYLES DAVID C Officer |
Sale at price 8.66 - 9.39 per share. | Direct | 234,916 | Dec 11, 2024 |
| BOHEN SEAN Chief Executive Officer |
Sale at price 8.66 - 9.39 per share. | Direct | 986,365 | Dec 11, 2024 |
| ZOJWALLA NASEEM M.D. Officer |
Sale at price 8.66 - 9.39 per share. | Direct | 250,456 | Dec 11, 2024 |
| KOVACS SHANE WILLIAM CHARLES Officer |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 9, 2024 |
| HARMON CYRUS Director |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 9, 2024 |
| MYLES DAVID C Officer |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 9, 2024 |
| BOHEN SEAN Chief Executive Officer |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 9, 2024 |
| ZOJWALLA NASEEM M.D. Officer |
Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 9, 2024 |
| KOVACS SHANE WILLIAM CHARLES Chief Operating Officer |
Conversion of Exercise of derivative security at price 7.02 per share. | Direct | 175,500 | Nov 15, 2024 |
